JPS58209993A - インタ−フエロンの産生方法 - Google Patents

インタ−フエロンの産生方法

Info

Publication number
JPS58209993A
JPS58209993A JP57092583A JP9258382A JPS58209993A JP S58209993 A JPS58209993 A JP S58209993A JP 57092583 A JP57092583 A JP 57092583A JP 9258382 A JP9258382 A JP 9258382A JP S58209993 A JPS58209993 A JP S58209993A
Authority
JP
Japan
Prior art keywords
medium
interferon
polyhydric alcohol
cells
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57092583A
Other languages
English (en)
Japanese (ja)
Other versions
JPS645878B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
Masahiro Nobuhara
延原　正弘
Kiyoshi Yamaguchi
清 山口
Suguru Mochida
持田　英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Priority to JP57092583A priority Critical patent/JPS58209993A/ja
Priority to US06/496,506 priority patent/US4548900A/en
Priority to GB08314400A priority patent/GB2121806B/en
Priority to CA000429218A priority patent/CA1195274A/en
Priority to DE19833319714 priority patent/DE3319714A1/de
Priority to FR8309002A priority patent/FR2527448B1/fr
Publication of JPS58209993A publication Critical patent/JPS58209993A/ja
Publication of JPS645878B2 publication Critical patent/JPS645878B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP57092583A 1982-05-31 1982-05-31 インタ−フエロンの産生方法 Granted JPS58209993A (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP57092583A JPS58209993A (ja) 1982-05-31 1982-05-31 インタ−フエロンの産生方法
US06/496,506 US4548900A (en) 1982-05-31 1983-05-20 Method of interferon production
GB08314400A GB2121806B (en) 1982-05-31 1983-05-25 Method of interferon production
CA000429218A CA1195274A (en) 1982-05-31 1983-05-30 Method of interferon production
DE19833319714 DE3319714A1 (de) 1982-05-31 1983-05-31 Verfahren zur interferonherstellung
FR8309002A FR2527448B1 (fr) 1982-05-31 1983-05-31 Procede de production d'interferon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57092583A JPS58209993A (ja) 1982-05-31 1982-05-31 インタ−フエロンの産生方法

Publications (2)

Publication Number Publication Date
JPS58209993A true JPS58209993A (ja) 1983-12-07
JPS645878B2 JPS645878B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-02-01

Family

ID=14058451

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57092583A Granted JPS58209993A (ja) 1982-05-31 1982-05-31 インタ−フエロンの産生方法

Country Status (6)

Country Link
US (1) US4548900A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS58209993A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1195274A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3319714A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2527448B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2121806B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6274284A (ja) * 1985-09-27 1987-04-06 Teijin Ltd 動物細胞の培養方法
JPS62285780A (ja) * 1986-06-04 1987-12-11 Agency Of Ind Science & Technol 動物細胞増殖用組成物および増殖方法

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58209993A (ja) * 1982-05-31 1983-12-07 Mochida Pharmaceut Co Ltd インタ−フエロンの産生方法
US4551429A (en) * 1983-09-15 1985-11-05 American Home Products Corporation Stimulation of antigen production by Bordetella pertussis
EP0248656B1 (en) * 1986-06-04 1993-03-31 Director-General of the Agency of Industrial Science and Technology Composition for cell cultivation and use thereof
JP2520681B2 (ja) * 1986-08-04 1996-07-31 ザ ユニバーシティ オブ ニュー サウス ウェールズ 生合成のヒトの成長ホルモン製品
US4961969A (en) * 1987-05-11 1990-10-09 Cetus Corporation Process for recovering microbially produced interferon-β
CA2190510A1 (en) * 1995-03-17 1996-09-26 Saburo Sone Corneal angiogenesis inhibitor
US6855519B2 (en) 1995-08-22 2005-02-15 The Regents Of The University Of California Methods for enhancing the production of interferon in cell culture
US5840565A (en) * 1995-08-22 1998-11-24 The Regents Of The University Of California Methods for enhancing the production of viral vaccines in PKR-deficient cell culture
US7367961B2 (en) * 2004-09-10 2008-05-06 Depuy Spine, Inc. Intradiscal injection of autologous interferon

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3413198A (en) * 1966-06-30 1968-11-26 Calbiochem Reagents and method for assaying biological samples
US3876375A (en) * 1971-11-22 1975-04-08 Jonas Maurukas Biological composition for use as a reference control in diagnostic analysis
EP0005476B1 (de) * 1978-05-17 1981-12-30 Dr. Karl Thomae GmbH Verfahren zur Herstellung von Humaninterferon
EP0014050A3 (en) * 1979-01-16 1980-10-01 Beecham Group Plc Interferon production
US4198479A (en) * 1979-03-30 1980-04-15 Merck & Co., Inc. Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells
JPS58209993A (ja) * 1982-05-31 1983-12-07 Mochida Pharmaceut Co Ltd インタ−フエロンの産生方法
US4462940A (en) * 1982-09-23 1984-07-31 Cetus Corporation Process for the recovery of human β-interferon-like polypeptides

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6274284A (ja) * 1985-09-27 1987-04-06 Teijin Ltd 動物細胞の培養方法
JPS62285780A (ja) * 1986-06-04 1987-12-11 Agency Of Ind Science & Technol 動物細胞増殖用組成物および増殖方法

Also Published As

Publication number Publication date
CA1195274A (en) 1985-10-15
FR2527448B1 (fr) 1986-12-12
DE3319714C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-05-11
GB2121806A (en) 1984-01-04
GB2121806B (en) 1985-06-26
DE3319714A1 (de) 1983-12-01
JPS645878B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-02-01
US4548900A (en) 1985-10-22
GB8314400D0 (en) 1983-06-29
FR2527448A1 (fr) 1983-12-02

Similar Documents

Publication Publication Date Title
CN1098103C (zh) 交感人类白细胞干扰素的制药用途
Pace et al. Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-gamma.
Stewart et al. Priming: a nonantiviral function of interferon
Chester et al. Suppression of mouse antibody producing spleen cells by various interferon preparations
JPS58209993A (ja) インタ−フエロンの産生方法
Dahl et al. The effect of ascorbic acid on production of human interferon and the antiviral activity in vitro
Cantell et al. Circulating interferon in rabbits after administration of human interferon by different routes
Havell et al. Synthesis of two distinct interferons by human fibroblasts
Hilleman Interferon induction and utilization
Zeleznick et al. Treatment of leukemic (L-1210) mice with double-stranded polyribonucleotides
Jameson et al. Bluetongue virus, an exceptionally potent interferon inducer in mice
CN101137391A (zh) 重组高效复合干扰素的用途
De Maeyer et al. Interferons
JPH0112760B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
Lehmann et al. Infection of macrophages by influenza A virus: characteristics of tumour necrosis factor-α (TNFα) gene expression
CN1059659A (zh) 病毒性肝炎的诊断和治疗
JPS6219406B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2005519091A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
Stringfellow et al. Hyporeactivity of infection: potential limitation to therapeutic use of interferon-inducing agents
Sehgal et al. Interferon and its inducers
Duc-Goiran et al. Unusual human interferons produced by virus-infected amniotic membranes.
Dussaix et al. Purification of highly radioactive mouse interferon produced by Ehrlich ascites tumour cells induced by Sendai virus
Trapman A systematic study of interferon production by mouse L-929 cells induced with poly (I)-poly (C) and DEAE-dextran
Degré Influence of polyinosinic: polycytidylic acid on the circulating white blood cells in mice
Hilleman et al. Double-stranded RNA’s in relation to interferon induction and adjuvant activity